Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Pankhurst, C.L.
and
Philpott-Howard, J.
1996.
The environmental risk factors associated with medical and dental equipment in the transmission of Burkholderia (Pseudomonas) cepacia in cystic fibrosis patients.
Journal of Hospital Infection,
Vol. 32,
Issue. 4,
p.
249.
Ensor, E.
Humphreys, H.
Peckham, D.
Webster, C.
and
Knox, A.J.
1996.
Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy?.
Journal of Hospital Infection,
Vol. 32,
Issue. 1,
p.
9.
Cazzola, G
Amalfitano, G
Tonolli, E
Perazzoli, C
Piacentini, I
and
Mastella, G
1996.
Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger‐printing study.
Acta Paediatrica,
Vol. 85,
Issue. 5,
p.
554.
Renders, N.H.M.
Sijmons, M.A.F.
Belkum, A.van
Overbeek, S.E.
Mouton, J.W.
and
Verbrugh, H.A.
1997.
Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings.
Research in Microbiology,
Vol. 148,
Issue. 5,
p.
447.
Lu, Daniel C.-T.
Chang, Shan-Chwen
Chen, Yee-Chun
Luh, Kwen-Tay
and
Hsieh, Wei-Chuan
1997.
In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood.
Diagnostic Microbiology and Infectious Disease,
Vol. 28,
Issue. 4,
p.
187.
LiPuma, John J.
1998.
BURKHOLDERIA CEPACIA.
Clinics in Chest Medicine,
Vol. 19,
Issue. 3,
p.
473.
Saiman, Lisa
MacDonald, Noni
Burns, Jane L.
Hoiby, Niels
Speert, David P.
and
Weber, David
2000.
Infection control in cystic fibrosis: Practical recommendations for the hospital, clinic, and social settings.
American Journal of Infection Control,
Vol. 28,
Issue. 5,
p.
381.
Parke, Jennifer L.
and
Gurian-Sherman, Doug
2001.
DIVERSITY OF THEBURKHOLDERIA CEPACIACOMPLEX ANDIMPLICATIONS FORRISKASSESSMENT OFBIOLOGICALCONTROLSTRAINS.
Annual Review of Phytopathology,
Vol. 39,
Issue. 1,
p.
225.
Speert, David P.
Henry, Deborah
Vandamme, Peter
Corey, Mary
and
Mahenthiralingam, Eshwar
2002.
Epidemiology ofBurkholderia cepaciaComplex in Patients with Cystic Fibrosis, Canada.
Emerging Infectious Diseases,
Vol. 8,
Issue. 2,
p.
181.
Rosenberg, Jon
and
Macher, Janet M.
2003.
Encyclopedia of Environmental Microbiology.
Lo Cascio, G.
Bonora, M.G.
Zorzi, A.
Mortani, E.
Tessitore, N.
Loschiavo, C.
Lupo, A.
Solbiati, M.
and
Fontana, R.
2006.
A napkin-associated outbreak of Burkholderia cenocepacia bacteraemia in haemodialysis patients.
Journal of Hospital Infection,
Vol. 64,
Issue. 1,
p.
56.
Woods, Donald E.
and
Sokol, Pamela A.
2006.
The Prokaryotes.
p.
848.
Schelstraete, P.
Van daele, S.
De Boeck, K.
Proesmans, M.
Lebecque, P.
Leclercq-Foucart, J.
Malfroot, A.
Vaneechoutte, M.
and
De Baets, F.
2008.
Pseudomonas aeruginosain the home environment of newly infected cystic fibrosis patients.
European Respiratory Journal,
Vol. 31,
Issue. 4,
p.
822.
Boronat García, Miguel
Abenza Baeza, Salomé
Martínez-Toldos, Carmen
and
Yagüe Guirao, Genoveva
2008.
Queratitis por Burkholderia cepacia.
Medicina Clínica,
Vol. 131,
Issue. 15,
p.
599.
Mann, T.
Ben-David, D.
Zlotkin, A.
Shachar, D.
Keller, N.
Toren, A.
Nagler, A.
Smollan, G.
Barzilai, A.
and
Rahav, G.
2010.
An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients.
Infection,
Vol. 38,
Issue. 3,
p.
187.
Remold, Susanna K.
Brown, Christopher K.
Farris, Justin E.
Hundley, Thomas C.
Perpich, Jessica A.
and
Purdy, Megan E.
2011.
Differential Habitat Use and Niche Partitioning by Pseudomonas Species in Human Homes.
Microbial Ecology,
Vol. 62,
Issue. 3,
p.
505.
Hayes, M. Melissa
Hughes, Thomas A.
and
Greene, Annel K.
2012.
Bacterial Diversity in Dried Colostrum and Whey Sold as Nutraceutical Products.
Journal of Food Science,
Vol. 77,
Issue. 7,
Meena, Suneeta
Bir, Raunak
Sood, Seema
and
Das, Bimal Kumar
2019.
Emergence of Burkholderia cepacia in ICU Setting.
Indian Journal of Critical Care Medicine,
Vol. 23,
Issue. 9,
p.
423.